Document is current
Any future updates will be listed below
-
Authors
Erickson, John J. https://orcid.org/0000-0001-6189-9302
Archer-Hartmann, Stephanie
Yarawsky, Alexander E. https://orcid.org/0000-0002-5973-5058
Miller, Jeanette L. C.
Seveau, Stephanie
Shao, Tzu-Yu
Severance, Ashley L.
Miller-Handley, Hilary https://orcid.org/0000-0001-6805-6025
Wu, Yuehong https://orcid.org/0000-0003-3590-2090
Pham, Giang
Wasik, Brian R. https://orcid.org/0000-0001-5442-3883
Parrish, Colin R. https://orcid.org/0000-0002-1836-6655
Hu, Yueh-Chiang https://orcid.org/0000-0002-7992-0525
Lau, Joseph T. Y. https://orcid.org/0000-0002-5128-2664
Azadi, Parastoo
Herr, Andrew B. https://orcid.org/0000-0002-3598-3399
Way, Sing Sing https://orcid.org/0000-0001-8948-1952
- License Information
-
More Information
Article History
Received: 27 June 2021
Accepted: 27 April 2022
First Online: 8 June 2022
Competing interests
: A patent on antibody sialic acid modification has been filed by Cincinnati Children’s Hospital, with J.J.E. and S.S.W. listed as inventors (PCT/US2022/018847). A.B.H. has equity in Chelexa BioSciencesand in Hoth Therapeutics, and he serves on the scientific advisory board of Hoth Therapeutics. The other authors declare no competing interests.
